Is the augmentation index a good marker of cardiovascular risk in Crohn's disease?

被引：0
|
作者：
Fissah, M. [1 ]
Rechach, A. [1 ]
Charifi, M. [1 ]
Menzou, F. [1 ]
Djouhri, M. [1 ]
Chibane, A. [1 ]
机构：
[1] Univ Hosp Ctr Douera, Dept Med, Algiers, Algeria
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.0499
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0325
引用
收藏
页码：i786 / i786
页数：1
相关论文
共 50 条
  • [21] The Crohn's Disease-Health Index
    Varma, Anika
    Weinstein, Jennifer
    Seabury, Jamison
    Rosero, Spencer
    Wagner, Ellen
    Zizzi, Christine
    Kaat, Aaron
    Luebbe, Elizabeth
    Dilek, Nuran
    Heatwole, John
    Saubermann, Lawrence
    Temple, Larissa
    Rogoff, Scott
    Heatwole, Chad
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (10) : 1043 - 1051
  • [22] VALIDATION OF THE LEMANN INDEX IN CROHN'S DISEASE
    Pariente, Benjamin
    Torres, Joana
    Burisch, Johan
    Arebi, Naila
    Barberio, Brigida
    Duricova, Dana
    Ellul, Pierre
    Goldis, Adrian
    Kaimakliotis, John
    Katsanos, Konstantinos
    Krznaric, Zeljko
    McNamara, Deirdre
    Pedersen, Natalia
    Sebastian, Shaji
    Weimars, Petra
    Lung, Phillip
    Lacognata, Carmelo
    Horak, Martin
    Domislovic, Viktor
    Murphy, Ian G.
    Azahaf, Mustapha
    Ungaro, Ryan C.
    Colombel, Jean Frederic
    Mary, Jean-Yves
    GASTROENTEROLOGY, 2020, 158 (06) : S469 - S469
  • [23] Fecal Calprotectin: A Marker of Crohn's Disease Activity
    Maksic, Mladen
    Veljkovic, Tijana
    Cvetkovic, Mirjana
    Markovic, Marija
    Peric, Sasa
    Marinkovic, Olivera
    Zdravkovic, Natasa
    ACTA FACULTATIS MEDICAE NAISSENSIS, 2023, 40 (02) : 160 - 170
  • [24] Microalbuminuria Is Not a Valuable Marker for Relapse in Crohn's Disease
    Horjus, C. S.
    van Oijen, M. G. H.
    Davids, A. H.
    Naber, A. H. J.
    de Jong, D. J.
    DIGESTION, 2011, 83 (1-2) : 41 - 45
  • [25] Faecal calprotectin: a new marker for Crohn's disease?
    Wassell, J
    Dolwani, S
    Metzner, M
    Losty, H
    Hawthorne, A
    ANNALS OF CLINICAL BIOCHEMISTRY, 2004, 41 : 230 - 232
  • [26] Do anti TNF alpha drugs reduce cardiovascular risk in Crohn's disease ?
    Fissah, M.
    Rechach, A.
    Charifi, M.
    Menzou, F.
    Djouhri, M.
    Taharboucht, S.
    Karch, A.
    Talbi, L.
    Touati, N.
    Chibane, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1630 - I1630
  • [27] Mesalazine: also a good choice in Crohn's disease
    Vetter, Christine
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2009, 47 (06): : 632 - 632
  • [28] Overestimation of waist-hip index as a marker of cardiovascular risk
    Michela Roman, B-C
    Gonzales-Huaman, Flor
    Maguina, Jorge L.
    NUTRICION HOSPITALARIA, 2016, 33 (04) : 1012 - 1012
  • [29] Relationship of the Pediatric Crohn's Disease Activity Index (PCDAI) and Crohn's Disease Activity Index (CDAI) in IMAgINE 1
    Turner, Dan
    Hyams, Jeffrey S.
    Dubinsky, Marla
    Faubion, William A.
    Eichner, Samantha
    Li, Yao
    Lazar, Andreas
    Huang, Bidan
    Thakkar, Roopal
    GASTROENTEROLOGY, 2015, 148 (04) : S640 - S640
  • [30] Arterial Pulse Wave Velocity but not Augmentation Index is Associated with Cardiovascular Risk
    Xiao, Wenkai
    Ye, Ping
    Luo, Leiming
    CIRCULATION, 2010, 122 (02) : E377 - E377
12345